Brighter's CEO comments on the board changes: "I understand the frustration but I am confident about the future”
Yesterday, three board members resigned. Due to this, the company has today called for an Extraordinary General Meeting on July 31, 2020, to appoint a new Board of Directors.
“I understand the frustration due to the turbulent situation in the board, but I am confident about the future and I want to emphasize that the operational work can continue with the board decisions that have been already made. Therefore, this has no significant effect on our plans, or the operational work,” says Brighter's CEO Henrik Norström.
Brighter's Chairman of the Board, Truls Sjöstedt, will remain Chairman until the EGM, but has announced that he will then leave his board seat at the disposal of the meeting.
“I could have resigned at the same time as the others, as one person's resignation was enough for the board to lose its function, but I chose to remain until the Extraordinary General Meeting, as it is important for me to take responsibility for the business even if the board work is now automatically paused. Personally, I think it is unfortunate that they did not remain until the meeting on July 31, so that it could be avoided that the share received observation status. However, the practical decisions for the near future were made before their resignation, meaning that this event has no significant effect on the company's operations,” says Truls Sjöstedt, Brighter's founder and Chairman.
Recently, the company obtained EC certificates (CE marking) for its new product Actiste Mini - which opens up the possibility of targeting the entire diabetes population, and not just insulin-treated as before, i.e. a significantly larger market. Now the work continues to finalize the complete service for this, and prepare it for the market. The company also has extensive discussions in Southeast Asia regarding new collaborations, as well as additional plans to amplify the company structure in the region, in parallel to the pilot project planned in the United Arab Emirates as soon as the product registration has been completed by the authorities.
“We are in an exciting and important phase with so much going on around the world. I am proud of our team members, we have a great offer to the market and I believe in our strategy. Step by step, we will now be reaching new achievements, strengthening the company's position over time,” says Henrik Norström.
For further information, please contact:
Henrik Norström, CEO
+46 733 40 30 45
henrik.norstrom@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.